Jpmorgan Chase & CO Prime Medicine, Inc. Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 38,187 shares of PRME stock, worth $153,893. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38,187
Previous 42,081
9.25%
Holding current value
$153,893
Previous $294,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding PRME
# of Institutions
121Shares Held
64.3MCall Options Held
127KPut Options Held
51.3K-
Alphabet Inc. Mountain View, CA15.1MShares$60.7 Million4.87% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.08MShares$24.5 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.66MShares$22.8 Million0.21% of portfolio
-
Black Rock Inc. New York, NY5.11MShares$20.6 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.73MShares$15 Million0.01% of portfolio
About Prime Medicine, Inc.
- Ticker PRME
- Shares Outstandng 95,730,200
- Market Cap $386M